FDA Drug Application (202545) for GRISEOFULVIN,ULTRAMICROSIZE by SIGMAPHARM LABS LLC

Back to FDA Applications sponsored by SIGMAPHARM LABS LLC

Application Number202545
Product Number001
FormTABLET;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGRISEOFULVIN,ULTRAMICROSIZE
Active IngredientGRISEOFULVIN, ULTRAMICROSIZE

Active IngredientCount
List of drugs with Active Ingredient GRISEOFULVIN, ULTRAMICROSIZE3


Back to FDA Applications sponsored by SIGMAPHARM LABS LLC